Sensome

✨ Going to BRAIN conference is like stepping into the future of neurovascular intervention and Sensome is proud to be a sponsor! Once again an exciting program is waiting in London and online!    💡 Do not miss Andrew Cheung's presentation of the results from the CLOT OUT trial on Tuesday morning! We look forward to seeing you next week!

Do not miss your chance to meet our CEO at the Medtronic Neurovascular Co-Lab event at the Society of Vascular and Interventional Neurology (SVIN) 2024 meeting and experience our clot-sensing technology!

🚀 We’re Hiring! Sensome is looking for a Lead IT Infrastructure Engineer to join our team!   If you are passionate about IT infrastructure and looking for your next challenge, we’d love to hear from you.   📍 Apply now via job@sensome.com or feel free to share this opportunity with your network!

🎉 November is lung cancer awareness month, and we are thrilled to announce that we have enrolled the first patient in France into the INSPECT feasibility clinical study evaluating the ability of our tissue microsensor technology to successfully identify lung lesion tissue, and differentiate between healthy and diseased tissue during transbronchial biopsy of endobronchial tumors and peripheral lung nodules. 💡 Our real-time tissue characterization sensor technology aims to enable physicians to pinpoint biopsy sites with precision, helping to reduce delays in diagnosing and treating lung cancer. 🙏 A special thank you to Dr. Amir Hanna, coordinating investigator of the study, and his team at Hôpitaux Saint-Joseph & Marie-Lannelongue for their hard work and commitment in successfully enrolling the first patient in France. David Fielding

Julie is looking to reinforce our team with a medical writer! If you love communicating exciting clinical results to the scientific community then you should apply today!

Sensome is HIRING It was my intention to stay 2 years at Sensome.   However, the technology, the entrepreneurship, the team and team spirit makes that I still love my assignment after 4 years. As the company is evolving further, Sensome is looking for a SCIENTIFIC and MEDICAL WRITER.

What an incredible and unexpected way to open Day 3 of WFITN NEW YORK 2024: Prof. Jacques Moret, a pioneer of neurovascular intervention, presents Sensome's sensor technology as a technology that will transform medicine. #WFITN2024 #innovation #medtech

What an incredible and unexpected way to open Day 3 of WFITN NEW YORK 2024: Prof. Jacques Moret, a pioneer of neurovascular intervention, presents Sensome's sensor technology as a technology that will transform medicine. #WFITN2024 #innovation #medtech

Today at 4:15pm Dr. Hal Rice will present results from our first-in-human CLOT OUT trial! Do not miss this this opportunity to learn more about our clot sensing technology and how it could impact the treatment of ischemic stroke patients. It's seasion AS-01 at WFITN NEW YORK 2024! #WFITN2024 Aymeric Rouchaud Suzana Saleme Laetitia de Villiers Vinicius Carraro do Nascimento Nathan Manning Andrew Cheung Ram Kadirvel David Liebeskind

📢 Hiring a Scientific and Medical Writer at Sensome ! Join the adventure of a dynamic and innovative medtech small company. You'll be at the heart of a complex medical device combining hardware and software challenges. Lot's of fun !